Erlotinib Active Not Recruiting Phase 2 Trials for Head and Neck Carcinoma Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01927744Study of Chemotherapy With Cisplatin/Carboplatin, and Docetaxel With or Without Erlotinib in Patients With Head and Neck Squamous Cell Carcinomas Amenable for Surgical Resection
NCT00076310OSI-774/Cisplatin/Taxotere in Head & Neck Squamous Cell Cancer